NASDAQ:VXRT
Vaxart Stock News
$1.30
+0.0100 (+0.775%)
At Close: Mar 28, 2024
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
08:00am, Wednesday, 27'th Mar 2024
SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccin
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
08:00am, Thursday, 07'th Mar 2024
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the full year ended Dece
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?
01:00pm, Monday, 26'th Feb 2024
Does VAXART, INC. (VXRT) have what it takes to be a top stock pick for momentum investors?
5 Top-Ranked Stocks That Have More Than Doubled Year to Date
10:11am, Friday, 23'rd Feb 2024
Amid the broad-market rally, shares of Equillium (EQ), Phunware (PHUN), Super Micro Computer (SMCI), Vaxart (VXRT) and Dianthus Therapeutics (DNTH) have more than doubled this year.
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?
10:56am, Tuesday, 20'th Feb 2024
VAXART, INC. (VXRT) reached a significant support level, and could be a good pick for investors from a technical perspective.
Vaxart, Inc. (VXRT) Q3 2023 Earnings Call Transcript
07:37pm, Thursday, 02'nd Nov 2023
Vaxart, Inc. (NASDAQ:VXRT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Andrei Floroiu - President and CEO James Cummings - Chief Medical Officer Phil Lee - CFO B
Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19
08:00am, Wednesday, 11'th Oct 2023
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief
3 Biotech Blockbusters to Turn $5,000 Into $50,000
12:48pm, Tuesday, 12'th Sep 2023
Investing in biotech stock can provide investors with immense rewards but also substantial risks. The key is finding the right balance.
Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now
03:26pm, Tuesday, 15'th Aug 2023
After losing some value lately, a hammer chart pattern has been formed for VAXART, INC. (VXRT), indicating that the stock has found support.
Vaxart, Inc. (VXRT) Q2 2023 Earnings Call Transcript
07:40pm, Thursday, 03'rd Aug 2023
Start Time: 16:30 January 1, 0000 5:01 PM ET Vaxart, Inc. (NASDAQ:VXRT ) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 PM ET Company Participants Andrei Floroiu - President and CEO James Cum
VAXART, INC. (VXRT) Reports Q2 Loss, Tops Revenue Estimates
06:46pm, Thursday, 03'rd Aug 2023
VAXART, INC. (VXRT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19.
Why Is Vaxart (VXRT) Stock Down 25% Today?
09:29am, Wednesday, 07'th Jun 2023
Vaxart (NASDAQ: VXRT ) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering. According to a press release from Vaxart, the company is ho
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
05:30am, Monday, 24'th Apr 2023
Novavax and Vaxart both were early favorites in the coronavirus vaccine race -- but the two companies fell behind. Since then, they've cut costs and shifted strategies.
Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
08:00am, Friday, 17'th Mar 2023
Company to provide a detailed overview of its norovirus clinical program
Vaxart, Inc. (VXRT) Q4 2022 Earnings Call Transcript
08:51pm, Wednesday, 15'th Mar 2023
Vaxart, Inc. (NASDAQ:VXRT ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Brant Biehn - Senior Vice President, Business Operations Andrei Floroiu - Chief Executive Of